MRSH Strangle Strategy
MRSH (Marsh & McLennan Companies, Inc.), in the Financial Services sector, (Insurance - Brokers industry), listed on NYSE.
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals. This entity serves as the parent company for several prominent advisory and consulting brands. These include Marsh, renowned for its insurance brokerage services; Guy Carpenter, a specialist in risk and reinsurance; Mercer, which provides comprehensive human resources and investment-related financial advice; and Oliver Wyman Group, an influential management and economic consultancy. Marsh & McLennan structures its operations into two core business segments. The "Risk and Insurance Services" division encompasses activities such as risk management, along with comprehensive insurance and reinsurance brokerage and services.
MRSH (Marsh & McLennan Companies, Inc.) trades in the Financial Services sector, specifically Insurance - Brokers, with a market capitalization of approximately $90.13B, a trailing P/E of 22.87, a beta of 0.58 versus the broader market, a 52-week range of 156.6-213.8, average daily share volume of 2.8M, a public-listing history dating back to 1987, approximately 95K full-time employees. These structural characteristics shape how MRSH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.58 indicates MRSH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. MRSH pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on MRSH?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
MRSH snapshot
As of August 14, 2026, spot at $188.34, ATM IV 20.70%, IV rank 2.89%, expected move 5.93%. The strangle on MRSH below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this strangle structure on MRSH specifically: MRSH IV at 20.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a MRSH strangle, with a market-implied 1-standard-deviation move of approximately 5.93% (roughly $11.18 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MRSH expiries trade a higher absolute premium for lower per-day decay. Position sizing on MRSH should anchor to the underlying notional of $188.34 per share and to the trader's directional view on MRSH stock.
MRSH strangle setup
The MRSH strangle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MRSH at $188.34 on that close, the first option leg uses a $200.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MRSH chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MRSH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $200.00 | $1.08 |
| Buy 1 | Put | $180.00 | $1.53 |
MRSH strangle risk and reward
- Net Premium / Debit
- -$260.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$260.00
- Breakeven(s)
- $177.40, $202.60
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
MRSH strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on MRSH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$17,739.00 |
| $41.65 | -77.9% | +$13,574.81 |
| $83.29 | -55.8% | +$9,410.62 |
| $124.94 | -33.7% | +$5,246.43 |
| $166.58 | -11.6% | +$1,082.24 |
| $208.22 | +10.6% | +$561.95 |
| $249.86 | +32.7% | +$4,726.15 |
| $291.50 | +54.8% | +$8,890.34 |
| $333.15 | +76.9% | +$13,054.53 |
| $374.79 | +99.0% | +$17,218.72 |
When traders use strangle on MRSH
Strangles on MRSH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MRSH chain.
MRSH thesis for this strangle
The market-implied 1-standard-deviation range for MRSH extends from approximately $177.16 on the downside to $199.52 on the upside. A MRSH long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current MRSH IV rank near 2.89% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MRSH at 20.70%. As a Financial Services name, MRSH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MRSH-specific events.
MRSH strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MRSH positions also carry Financial Services sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MRSH alongside the broader basket even when MRSH-specific fundamentals are unchanged. Always rebuild the position from current MRSH chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on MRSH?
- A strangle on MRSH is the strangle strategy applied to MRSH (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With MRSH stock at $188.34 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed MRSH chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are MRSH strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MRSH strangle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 20.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$260.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MRSH strangle?
- The breakeven for the MRSH strangle priced on this page is roughly $177.40 and $202.60 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MRSH market-implied 1-standard-deviation expected move in the same options snapshot is approximately 5.93%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on MRSH?
- Strangles on MRSH are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MRSH chain.
- How does current MRSH implied volatility affect this strangle?
- MRSH ATM IV is at 20.70% with IV rank near 2.89%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.